Takeda Pharmaceuticals U.S.A., Inc. (CIK 1716229) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Buy OVID (1.2M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Ovid Therapeutics Inc. (OVID) | 10% Owner | Buy | 1.2M | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-09